Short-term effects of surgery in post-menopausal patients with primary hyperparathyroidism and normal bone turnover

Journal of Endocrinological Investigation

Volumn 24, Issue 8, 2001, Pages 575-579

  Carnevale, V ^a   Pacitti, M T ^b   Pileri, M ^a   Paglia, F ^b   Scillitani, A ^a   Dionisi, S ^b   Caravella, P ^b   Romagnoli, E ^c   Minisola, S ^b  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c San Giovanni Battista Hospital   (Italy)

Author keywords

Bone turnover markers; Parathyroidectomy; Primary hyperparathyroidism

Indexed keywords

ALKALINE PHOSPHATASE; BIOCHEMICAL MARKER; COLLAGEN TYPE 1 CROSS LINKED N TELOPEPTIDE; COLLAGEN TYPE 1 TELOPEPTIDE; DEOXYPYRIDINOLINE; OSTEOCALCIN; PARATHYROID HORMONE; PEPTIDE; PYRIDINOLINE; UNCLASSIFIED DRUG;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BONE DENSITY; BONE DISEASE; BONE MINERAL; BONE TURNOVER; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; ENZYME ASSAY; FEMALE; FRACTURE; HUMAN; OSSIFICATION; OSTEOLYSIS; PARATHYROIDECTOMY; POSTMENOPAUSE OSTEOPOROSIS; POSTOPERATIVE PERIOD; PRIMARY HYPERPARATHYROIDISM; RECEPTOR UPREGULATION; REFERENCE VALUE; RISK ASSESSMENT; STATISTICAL ANALYSIS; TIME; TISSUE SPECIFICITY; URINARY EXCRETION;

BIOLOGICAL MARKERS; BONE DENSITY; BONE REMODELING; BONE RESORPTION; FEMALE; HUMANS; HYPERPARATHYROIDISM; MIDDLE AGED; POSTMENOPAUSE; REFERENCE VALUES; TIME FACTORS; TREATMENT OUTCOME; UP-REGULATION;

EID: 0034784361     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03343897     Document Type: Article

References (19)

1. Primary hyperparathyroidism: Incidence, morbidity, and potential economic impact in a community
2. Primary hyperparathyroidism
3. Risk of age-related fractures in patients with primary hyperparathyroidism
4. Fracture incidence in postmenopausal women with primary hyperparathyroidism
5. Diagnosis and management of asymptomatic primary hyperparathyroidism: Consensus Development Conference Statement
6. Assessment of serum total and bone alkaline phosphatase in clinical practice
7. Clinical validation of a new immunoradiometric assay for intact human osteocalcin
8. Serum osteocalcin and bone mineral density at various skeletal sites: A study performed with three different assays
9. Age-related changes of global skeletal uptake (GSU) of 99mTc-methylendiphosphonate in healthy women
10. The measurement of urinary amino-terminal telopeptides of type I collagen to monitor bone resorption in patients with primary hyperparathyroidism
11. Measurement of urinary free pyridinolines at the menopause and in elderly women: Is the sensitivity similar?
12. Prevalence of hypercalcemia in a health survey: A 14-year follow-up study of serum calcium values
13. Increased biochemical markers of bone formation and resorption in primary hyperparathyroidism with special reference to patients with mild disease
14. Concurrent assays of circulating bone gla-protein and bone alkaline phosphatase: Effects of sex, age, and metabolic bone disease
15. Urinary hydroxypyridinium cross-links of collagen in primary hyperparathyroidism
16. Direct, enzyme-linked immunoassay for urinary deoxypyridinoline as a specific marker for measuring bone resorption
17. Assessment of bone resorption with a new marker of collagen degradation in patients with metabolic bone disease
18. Response of several markers of bone collagen degradation to calcium supplementation in post-menopausal women with low calcium intake
19. Response of biochemical markers of bone turnover to hormone replacement therapy: Impact of biological variability